Video Experimental Relacionado
Updated: Aug 4, 2026
05:31
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Inmunoglobulina E y el síndrome de eczema-asma en la primera infancia
Lancet (London, England)
|January 9, 1982
Resumen
Los niveles séricos de inmunoglobulina E (IgE) se correlacionan con el desarrollo de síntomas atópicos en los bebés. Sin embargo, una porción significativa de los bebés con IgE alta o síntomas atópicos tenían niveles normales, lo que indica relaciones complejas.
Área de la Ciencia:
- Alergia e inmunología pediátrica.
- Inmunología Clínica Inmunología Clínica.
- La genética de las enfermedades atópicas.
Sus antecedentes:
- Las enfermedades atópicas, como el asma y el eccema, representan una carga significativa para la salud en la infancia.
- Los niveles elevados de inmunoglobulina E (IgE) en suero son un biomarcador conocido asociado con la atopia.
- Comprender el valor predictivo de la IgE sérica temprana en bebés de familias atópicas es crucial para la intervención temprana.
Objetivo del estudio:
- Investigar la relación entre las concentraciones séricas de IgE y el desarrollo de síntomas atópicos en lactantes.
- Evaluar el valor predictivo de la IgE sérica para la atopia en una población infantil de alto riesgo.
- Evaluar la influencia de la lactancia materna en el desarrollo de la atopia y los niveles de IgE.
Principales métodos:
- Estudio longitudinal de 250 bebés de familias con antecedentes de atopia.
- Medición de las concentraciones séricas de IgE.
- Evaluación clínica para el desarrollo de síntomas atópicos hasta los dos años de edad.
Principales resultados:
- Los síntomas atópicos se desarrollaron en el 17,6% de los bebés a los dos años.
- Los bebés con atopia definida mostraron niveles séricos promedio de IgE más altos en comparación con los bebés no afectados, aunque el 50% de los bebés afectados tenían IgE normal.
- La lactancia materna no demostró un efecto protector contra el desarrollo de atopia o niveles elevados de IgE.
Conclusiones:
- Si bien la elevación de la IgE sérica se asocia con la atopia en los bebés, no es un predictor definitivo debido a los niveles normales de IgE en muchos bebés afectados.
- Una proporción de bebés clínicamente no afectados mostró un aumento de la IgE sérica, lo que sugiere una sensibilización subclínica u otros factores que influyen en la atopia.
- La lactancia materna no ofrece protección contra el desarrollo de atopia o niveles anormales de IgE en esta cohorte.
Videos de Conceptos Relacionados
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
02:06Allergic Reactions
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...